AGER and neuropathy: At the molecular and cellular level, activation of the receptors for advanced glycation end products (RAGE) and nuclear factor kappa B (NF-κB) signaling advances the development of neurovascular dysfunction, neuropathy, and upregulation of pro-inflammatory cytokines [16].